- Home
- DAWN vs SFL Comparison
DAWN vs SFL Comparison
Compare DAWN & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- SFL
- Stock Information
- Founded
- DAWN 2018
- SFL 2003
- Country
- DAWN United States
- SFL Bermuda
- Employees
- DAWN N/A
- SFL N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- SFL Marine Transportation
- Sector
- DAWN Health Care
- SFL Consumer Discretionary
- Exchange
- DAWN Nasdaq
- SFL Nasdaq
- Market Cap
- DAWN 1.2B
- SFL 1.5B
- IPO Year
- DAWN 2021
- SFL N/A
- Fundamental
- Price
- DAWN $8.07
- SFL $8.17
- Analyst Decision
- DAWN Strong Buy
- SFL Strong Buy
- Analyst Count
- DAWN 7
- SFL 2
- Target Price
- DAWN $32.29
- SFL $14.50
- AVG Volume (30 Days)
- DAWN 1.3M
- SFL 1.5M
- Earning Date
- DAWN 05-05-2025
- SFL 05-13-2025
- Dividend Yield
- DAWN N/A
- SFL 13.23%
- EPS Growth
- DAWN N/A
- SFL 52.99
- EPS
- DAWN N/A
- SFL 1.01
- Revenue
- DAWN $131,161,000.00
- SFL $894,061,000.00
- Revenue This Year
- DAWN $28.72
- SFL N/A
- Revenue Next Year
- DAWN $73.78
- SFL $5.49
- P/E Ratio
- DAWN N/A
- SFL $8.08
- Revenue Growth
- DAWN N/A
- SFL 20.12
- 52 Week Low
- DAWN $7.88
- SFL $8.06
- 52 Week High
- DAWN $18.07
- SFL $14.62
- Technical
- Relative Strength Index (RSI)
- DAWN 36.05
- SFL 32.65
- Support Level
- DAWN $7.93
- SFL $8.13
- Resistance Level
- DAWN $8.44
- SFL $8.36
- Average True Range (ATR)
- DAWN 0.44
- SFL 0.26
- MACD
- DAWN 0.09
- SFL 0.03
- Stochastic Oscillator
- DAWN 17.59
- SFL 12.96
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.